In the News
November 30, 2022 | Duke School of Medicine
Aravind Asokan to Lead Partnership with Danaher Corporation to Accelerate Gene Therapy Breakthroughs
Aravind Asokan will lead a new strategic partnership with Danaher Corporation to form the first Danaher Beacon for Gene Therapy Innovation, a new initiative designed to access breakthrough science to create technologies and applications that will improve human health.
November 16, 2022 | Duke Research Blog
Gersbach is one of 30 Duke faculty to make this year's list
November 11, 2022 | Cision PR Newswire
Danaher Corporation (NYSE: DHR), a global science and technology innovator, today announced that it has entered a strategic partnership with Duke University to form its first Danaher Beacon for Gene Therapy Innovation.
October 13, 2022 | WRAL TechWire
The oncology startup Tavros Therapeutics has signed a five-year collaboration with Vividion Therapeutics that could bring as much as $430.5 million to the RTP firm.
October 5, 2022 | Duke Today
Editing technology is precise and broadly applicable to all tissues and animal species
October 4, 2022 | Duke CTSI
Svati H. Shah, MD, MHS, spoke to partners at the North Carolina Research Campus (NCRC) about the pivotal role of Duke Kannapolis at the 350-acre translational science hub focused on human health and nutrition.
September 6, 2022
We are excited to welcome Anoop Patel, MD, associate professor of neurosurgery, to the CAGT community. Patel graduated magna cum laude from Harvard Medical School and completed residency as well as a research fellowship at Massachusetts General Hospital. He comes to Duke [...]
July 20, 2022 | Duke School of Medicine
July 1, 2022
We are excited to welcome Pranam Chatterjee, PhD, assistant professor of biomedical engineering, to the CAGT community. Chatterjee's research focus explores how to develop cells and tissues that can improve reproductive longevity and fertility. “The work that I do is very [...]
June 6, 2022
By Alissa Kocer Leukemia starts in cells that would normally develop into different types of blood cells. About 61,000 people in the U.S. are diagnosed each year, and depending on the type of leukemia and the age of the patient, five-year survival rates vary between about [...]
April 28, 2022 | Gilbert Family Foundation
The Gilbert Family Foundation, announced more than $18 million in grants to fund a new three-year campaign as part of the organization’s Gene Therapy Initiative.
April 20, 2022 | Emory News Center
What if we could regulate the way genes are expressed? That question has long intrigued researchers, and a new collaboration between Duke and Emory University helps narrow the knowledge gap by showing for the first time that mRNA can be used to activate genes in animals.
March 31, 2022 | Duke Health News
Disrupting a key cell repair mechanism could extend the benefit of targeted therapies
March 10, 2022
At Duke, mentoring isn't just about trainees' scientific development. Our faculty care about our trainees' growth as individuals too.
February 11, 2022
The Center for Advanced Genomic Technologies (CAGT) provided fellowships to support postdoctoral trainees who are conducting research to develop and apply genomic technologies and methods for associated computational analyses to basic and applied biomedical sciences. We [...]
February 11, 2022 | Duke Precision Genomics Collaboratory
February 7, 2022 | Pratt School of Engineering
First approach to promote electrical excitation of heart cells in live mammals could lead to new gene therapy treatments for a wide range of heart diseases
November 16, 2021 | Duke Research Blog
October 25, 2021 | Duke School of Medicine
Jennifer Doudna, PhD, professor of chemistry, biochemistry, and molecular biology at the University of California, Berkeley, is a leading figure in the CRISPR revolution. Her fundamental work and leadership in developing the CRISPR-Cas9 genome editing tool earned her and French microbiologist Emmanuelle Charpentier the Nobel Prize in Chemistry in 2020.
October 7, 2021
Anne West, MD, PhD, professor of neurobiology, received a Faculty Scholar Award from the Ruth K Broad Biomedical Research Foundation to study noncoding regulation of gene transcription in human neurons. This three-year, $375,000 grant will leverage what researchers already [...]
September 9, 2021
Duke University is the recipient of two large grants totaling nearly $12 million from NHGRI.
August 23, 2021 | Working@Duke
August 2, 2021
A CRISPR-Cas9 variant with deactivated DNA-cutting function – known as “dCas9” - is a powerful tool to help researchers understand what genes do when their expression is dialed up or down, but it has some limitations.
July 12, 2021 | Duke Translation & Commercialization